NDC 45802-997 - clindamycin and benzoyl peroxide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 45802-997
- Package NDCs from labels
- 45802-997-01
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Effective date
- 2022-03-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| clindamycin and benzoyl peroxide - Padagis Israel Pharmaceuticals Ltd | Padagis Israel Pharmaceuticals Ltd | 2022-03-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45802-997-01 | clindamycin and benzoyl peroxide | 19.7 g in 1 JAR | GEL | 19.7 g | 50 mg in 1g | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acne Treatment | BENZOYL PEROXIDE | Topco Associates LLC | 8d5e7e40-5e61-470a-b8ff-0b2dca3cabb0 | 2026-02-13 | Warnings, Adverse reactions | W9WZN9A0GM |
| Daily Acne Control Cleanser | BENZOYL PEROXIDE | Topco Associates LLC | 8474d917-7ee4-4d1d-8499-3520f771d2fd | 2026-02-13 | Warnings, Adverse reactions | W9WZN9A0GM |
| Acne Treatment | BENZOYL PEROXIDE | Walgreen Co. | 07721aa6-867a-436f-8c88-ab135f02a6b5 | 2026-02-12 | Warnings, Adverse reactions | W9WZN9A0GM |
| Acne Cleanser | BENZOYL PEROXIDE | Walmart, Inc. | 04514cbb-6041-4bd5-9ab9-31312b0d8f19 | 2026-02-06 | Warnings, Adverse reactions | W9WZN9A0GM |
| SPOTLESS Daily Acne Wash | BENZOYL PEROXIDE | Rodan & Fields | 8f7bb793-3c60-4014-954e-514ef87a44fb | 2026-02-04 | Warnings | W9WZN9A0GM |
| SPOTLESS Acne Clearing Treatment | BENZOYL PEROXIDE | Rodan & Fields | 3d4ef4ce-9be3-436a-9f93-c01caa93d1a8 | 2026-02-04 | Warnings | W9WZN9A0GM |
| Stool Softener Laxative | DOCUSATE SODIUM | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | cb2698b1-6c58-417f-ae86-74fbe3814626 | 2026-02-03 | Warnings | F05Q2T2JA0 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE USP, 1% | A-S Medication Solutions | 193a4b02-910f-46b2-8b61-25efea694720 | 2026-02-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Acne Treatment | BENZOYL PEROXIDE | CVS Pharmacy, Inc. | d9fbaeba-cebf-4d02-aa7d-3ee1d2fdc50c | 2026-02-02 | Warnings, Adverse reactions | W9WZN9A0GM |
| clindamycin and benzoyl peroxide | CLINDAMYCIN AND BENZOYL PEROXIDE | Glenmark Pharmaceuticals Inc., USA | 76795d1b-e1f2-4d1d-b42a-f1d4448c63c0 | 2026-01-31 | Warnings, Adverse reactions | 358917 W9WZN9A0GM EH6D7113I8 |
| Acne Treatment | BENZOYL PEROXIDE | Rite Aid Corporation | a51b7668-1ba1-42cb-b804-4fdf76610695 | 2026-01-30 | Warnings, Adverse reactions | W9WZN9A0GM |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Strategic Sourcing Services, LLC | 905bd658-a0af-4f20-be3d-00c54868a26c | 2026-01-29 | Warnings | F05Q2T2JA0 |
| ZITFREE ACNE TREATMENT | BENZOYL PEROXIDE | Natureplex, LLC | 70c2e3fb-e643-467b-80fd-c40e3c3e9513 | 2026-01-29 | Warnings | W9WZN9A0GM |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d0ec3e88-40d9-4919-afc3-cf2e7e863376 | 2026-01-29 | Warnings, Adverse reactions | EH6D7113I8 |
| Stool Softener Laxative | DOCUSATE SODIUM | Meijer Distribution Inc. | 81edf0d8-b6f3-4b3a-85db-0108160756b1 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1ad73079-ebb3-dae7-e063-6294a90a0558 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 100MG | DOCUSATE SODIUM 100MG | Farmacias De Similares TX LLC | 44269b79-a5ad-f443-e063-6294a90a8473 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 997a23c8-f0d7-49d5-af33-e11f2ddab3c7 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMACEUTICALS INC., USA | d36bad26-f337-4a71-a6e5-d97b60f4e385 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 62a2019f-7410-4251-95ed-181925ade6e4 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.